Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Battling Enteropathogenic Clostridia: Phage Therapy for Clostridioides difficile and Clostridium perfringens
Jennifer Venhorst, J.M.B.M. van der Vossen, Valeria Agamennone
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 25

Showing 25 citing articles:

Alternatives Therapeutic Approaches to Conventional Antibiotics: Advantages, Limitations and Potential Application in Medicine
Hiba Alaoui Mdarhri, Rachid Benmessaoud, Houda Yacoubi, et al.
Antibiotics (2022) Vol. 11, Iss. 12, pp. 1826-1826
Open Access | Times Cited: 70
Insights into the Evolving Epidemiology of Clostridioides difficile Infection and Treatment: A Global Perspective
Crystal S. Liu, Tanya Monaghan, Abbas Yadegar, et al.
Antibiotics (2023) Vol. 12, Iss. 7, pp. 1141-1141
Open Access | Times Cited: 42
Gut Microbiota–Gut Metabolites and Clostridioides difficile Infection: Approaching Sustainable Solutions for Therapy
Bijay Gurung, Maranda Stricklin, Shaohua Wang
Metabolites (2024) Vol. 14, Iss. 1, pp. 74-74
Open Access | Times Cited: 13
THE ROLE OF TRADITIONAL CHINESE MEDICINE IN ADDRESSING THE CHALLENGES OF CLOSTRIDIAL GAS GANGRENE: A MULTIFACETED APPROACH
Pavithra Bharathy, Punniyakoti T. Veeraveedu
Pharmacological Research - Natural Products (2025), pp. 100198-100198
Closed Access
Characterization of Clostridium perfringens Phage Endolysin PlyDolk21
Suyoung Seo, Bo‐Kyung Son, Minsuk Kong
Antibiotics (2025) Vol. 14, Iss. 1, pp. 81-81
Open Access
The evolving landscape of live biotherapeutics in the treatment of Clostridioides difficile infection
Parul Berry, Sahil Khanna
Indian Journal of Gastroenterology (2025)
Closed Access
Advances in Antimicrobial Resistance and Alternative Therapy
Bagthasingh Chrisolite, Sourabh Debbarma, Sekar Gobinath
(2025), pp. 299-317
Closed Access
Static and Dynamic Assessments of a Sulfur-Triglyceride Composite for Antimicrobial Surface Applications
Shalini K. Wijeyatunga, Perla Y. Sauceda‐Oloño, Nawoda L. Kapuge Dona, et al.
Molecules (2025) Vol. 30, Iss. 7, pp. 1614-1614
Open Access
Mechanisms of Radix Rehmanniae Praeparata in Treating Blood Deficiency: A Study on Chemistry, Metabolomics, and Gut Microbiota
Runping Gao, F Wang, Xuwen Liu, et al.
CHINESE JOURNAL OF ANALYTICAL CHEMISTRY (CHINESE VERSION) (2025), pp. 100548-100548
Open Access
Clostridioides difficile S-Layer Protein A (SlpA) Serves as a General Phage Receptor
Alexia L. M. Royer, Andrew A. Umansky, Marie-Maude Allen, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 2
Open Access | Times Cited: 8
Necrotic enteritis and antibiotic-free production of broiler chickens: Challenges in testing and using alternative products
Robert J. Moore
Animal nutrition (2023) Vol. 16, pp. 288-298
Open Access | Times Cited: 8
Post-infectious ibs following Clostridioides difficile infection; role of microbiota and implications for treatment
Dana Taghaddos, Zarwa Saqib, Xiaopeng Bai, et al.
Digestive and Liver Disease (2024) Vol. 56, Iss. 11, pp. 1805-1809
Closed Access | Times Cited: 2
Dietary Effects on the Gut Phageome
Andrea Howard, Amanda Carroll‐Portillo, Joe Alcock, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8690-8690
Open Access | Times Cited: 2
A novel chimeric endolysin with enhanced lytic and binding activity against Clostridium perfringens
Yeweon Choi, Eunsu Ha, Minsuk Kong, et al.
LWT (2023) Vol. 181, pp. 114776-114776
Open Access | Times Cited: 6
Biofilm Formation of Clostridioides difficile, Toxin Production and Alternatives to Conventional Antibiotics in the Treatment of CDI
Leon M. T. Dicks
Microorganisms (2023) Vol. 11, Iss. 9, pp. 2161-2161
Open Access | Times Cited: 4
Foodborne Clostridioides Species: Pathogenicity, Virulence and Biocontrol Options
Mary Garvey
Microorganisms (2023) Vol. 11, Iss. 10, pp. 2483-2483
Open Access | Times Cited: 4
Gut Lactococcus garvieae promotes protective immunity to foodborne Clostridium perfringens infection
Xueyin Wang, Meng Fan-hua, Mingyue Zhang, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 10
Open Access | Times Cited: 1
Complete genome analysis and biological characterization of a novel phage vB_CP_qdyz_P5 with lytic activity against Clostridium perfringens
Guanhua Xuan, Gang Zhao, Yue Wang, et al.
Microbial Pathogenesis (2023) Vol. 183, pp. 106279-106279
Closed Access | Times Cited: 2
Bacteriófagos: los virus que se emplearán como agentes terapéuticos de las infecciones ocasionadas por bacterias multirresistentes a los antimicrobianos
Raúl Garza Velasco, Sylvia P. Garza-Manero, Rodolfo Pastelin‐Palacios, et al.
Educación Química (2024) Vol. 35, Iss. 3, pp. 140-149
Open Access
Bacteriophages: a double-edged sword in the gastrointestinal tract
Yuqi Wei, Chunli Zhou
Frontiers in Microbiomes (2024) Vol. 3
Open Access
An insight into the applications of bacteriophages against food-borne pathogens
Gutti Deepa, Irene Daniel, Shobana Sugumar
Journal of Food Science and Technology (2024) Vol. 62, Iss. 1, pp. 1-10
Closed Access
Broccoli alleviates metabolic-associated fatty liver disease through regulating gut flora and lipid metabolism via the FXR/LXR signaling pathway
Yingjian Lu, Xin Li, Shaotong Ma, et al.
Food & Function (2024)
Closed Access
A review on re-emerging bacteriophage therapy in the era of XDR
Pooja Bhadoriya, Richa Sharma, Rekha Mehrotra, et al.
Biocell (2023) Vol. 47, Iss. 9, pp. 1915-1930
Open Access | Times Cited: 1
The Clostridioides difficile S-Layer Protein A (SlpA) serves as a general phage receptor
Alexia L. M. Royer, Andrew A. Umansky, Marie-Maude Allen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Future of Engineered Phage Therapy for Clostridium difficile Infections
Amer Nubgan
Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ) (2023) Vol. 5, pp. 73-77
Open Access
Page 1

Scroll to top